Sign in
Taking people in United KingdomNo phase

Studying How Viruses Trigger Flare-Ups in Chronic Lung Disease

Follows adults with chronic lung disease, sampling them when well and during flare-ups.

Key facts

Who runs it
Imperial College London
Where
London, United KingdomSee the site
Trial code
Registry title
Exploring How Viral Infections Affect People With Chronic Lung Disease
Status
Recruiting
People taking part
180 people, planned
Started
1 Nov 2024
Expected to end
Apr 2027
Type of study
Observational
Record updated
14 July 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with long-term lung disease such as COPD or bronchiectasis who had a flare-up in the last year. It studies how viruses trigger flare-ups.

Age
18 Years and older
Sex
All sexes can join.
Disease stage
Chronic airway disease (for example COPD and bronchiectasis) confirmed by a doctor.
Earlier treatment
At least one flare-up in the last year that needed antibiotics and/or corticosteroids.

Main reasons for not taking part

  • Cannot complete daily symptom diaries or attend clinical assessments
  • Flare-up within 4 weeks of joining the study
  • Clinical instability at the time of joining
  • Pregnancy

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Adults with a physician confirmed diagnosis of chronic airway disease (e.g. COPD and bronchiectasis) according to established diagnostic criteria; AND
  • Prior history of exacerbation within last year (defined as requiring antibiotic and/or corticosteroids)

Who cannot take part

  • Inability to complete daily symptom diaries and/or attend for clinical assessments
  • Exacerbation within 4 weeks of study recruitment and/or clinical instability at the time of recruitment
  • Pregnancy

Where in United Kingdom

  • Royal Brompton HospitalLondon, United KingdomContact: Anand ShahTaking people

About the trial

What the trial wants to find out

Many people with chronic lung disease have disease flare-ups. It was previously believed that these were mainly caused by bacteria but recent evidence suggests that viruses could be an important trigger. This study will recruit volunteers with chronic lung disease and take samples both when well (at baseline) and during flare-ups (exacerbations) to better understand the role of viruses in triggering exacerbations and also how the immune response is affected. The researchers will follow the volunteers\' progress for up to two years. Whenever they get unwell they will take some samples (nose swabs, finger prick testing, phlegm sample) and post them to the researchers. Then, they will come in for a visit for more samples (blood tests, further swabs) and a review.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Prospective Cohort Study to Understand Impact of Viral Infection in Chronic Lung Disease
Plain-language title
Studying How Viruses Trigger Flare-Ups in Chronic Lung DiseaseGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
14 July 2025